Esperion recalls
FDA enforcement reports naming Esperion as the recalling firm.
- Recall reports
- 2
- Class I (serious)
- 0
- Most recent report
- Apr 24, 2024
- Apr 24, 2024NEXLIZET (bempedoic acid and ezetimibe) tablets, 180 mg/10 mg, 30-count bottle, Rx only…Drug · EsperionFailed dissolution specifications: out-of-specification bempedoic acid dissolution at the 0-month timepoint.Class III
- Sep 13, 2023Nexlizet (bempedoic acid and ezetimibe), 180ng/18mg, 30 tablets, Rx only, Manufactured…Drug · EsperionFailed dissolution specifications: below specification results at stability 12-monthClass III